396 Results

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Pao
    Pao
  4. Ladanyi
    Ladanyi
  5. O'Reilly
    O'Reilly
  6. Miller
    Miller
  7. Yu
    Yu
  8. Abou-Alfa
    Abou-Alfa
  9. Zakowski
    Zakowski
  10. Lacouture
    Lacouture

Groups

  1. Department of Medicine (237)
  2. Solid Tumor Oncology Division (203)
  3. Thoracic Oncology (97)
  4. GSK Faculty (87)
  5. Gastrointestinal Oncology Service (74)
  6. Tow Center for Developmental Oncology (TCDO) (70)
  7. Human Oncology and Pathogenesis Program (65)
  8. Department of Pathology and Laboratory Medicine (64)
  9. Center for Pancreatic Cancer Research (43)
  10. Surgery (43)
  1. "erlotinib"
Formats
  1. Journal Article (362)
  2. Review (16)
  3. Meeting Abstract (7)
  4. Conference Paper (4)
  5. Book Section (2)
  6. Editorial (2)
  7. Guidelines (2)
  8. Correspondence (1)
Groups
  1. Department of Medicine (237)
  2. Solid Tumor Oncology Division (203)
  3. Thoracic Oncology (97)
  4. GSK Faculty (87)
  5. Gastrointestinal Oncology Service (74)
  6. Tow Center for Developmental Oncology (TCDO) (70)

More Groups

People
  1. Mark Kris (53)
  2. Gregory Riely (51)
  3. Vincent Miller (45)
  4. William Pao (42)
  5. Marc Ladanyi (41)
  6. Eileen O'Reilly (28)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (6)
  6. 2020 (7)

More Years

Publications
  1. Clinical Cancer Research (35)
  2. Journal of Thoracic Oncology (33)
  3. Journal of Clinical Oncology (23)
  4. Cancer (12)
  5. Journal of the National Comprehensive Cancer Network (11)
  6. Supportive Care in Cancer (8)

More Publications

Publishers
  1. Elsevier Inc. (77)
  2. American Association for Cancer Research (45)
  3. American Society of Clinical Oncology (26)
  4. Oxford University Press (21)
  5. Springer (21)
  6. Wiley Blackwell (21)

More Publishers

Results (396)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations
    Journal Article

    Janjigian, Y. Y.; Park, B. J.; Zakowski, M. F.; Ladanyi, M.; Pao, W.; D'Angelo, S. P.; Kris, M. G.; Shen, R.; Zheng, J.; Azzoli, C. G.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus
    Journal Article

    Ilson, D. H.; Kelsen, D.; Shah, M.; Schwartz, G.; Levine, D. A.; Boyd, J.; Capanu, M.; Miron, B.; Klimstra, D.
    Cancer (2011)

    Fulltext@MSK | Save
  • Venous thromboembolic events with chemotherapy plus bevacizumab: A pooled analysis of patients in randomized phase II and III studies
    Journal Article

    Hurwitz, H. I.; Saltz, L. B.; Van Cutsem, E.; Cassidy, J.; Wiedemann, J.; Sirzén, F.; Lyman, G. H.; Rohr, U. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy
    Journal Article

    Brevet, M.; Shimizu, S.; Bott, M. J.; Shukla, N.; Zhou, Q.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
    Journal Article

    Bivona, T. G.; Hieronymus, H.; Parker, J.; Chang, K.; Taron, M.; Rosell, R.; Moonsamy, P.; Dahlman, K.; Miller, V. A.; Costa, C.; more...
    Nature (2011)

    Fulltext@MSK | Save
  • KRAS and BRAF: Drug targets and predictive biomarkers
    Journal Article

    Vakiani, E.; Solit, D. B.
    Journal of Pathology (2011)

    Fulltext@MSK | Save
  • Clinical cancer genomics: How soon is now?
    Journal Article

    Taylor, B. S.; Ladanyi, M.
    Journal of Pathology (2011)

    Fulltext@MSK | Save
  • Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors
    Journal Article

    Balagula, Y.; Garbe, C.; Myskowski, P. L.; Hauschild, A.; Rapoport, B. L.; Boers-Doets, C. B.; Lacouture, M. E.
    International Journal of Dermatology (2011)

    Fulltext@MSK | Save
  • The GIST paradigm: Lessons for other kinase-driven cancers
    Journal Article

    Antonescu, C. R.
    Journal of Pathology (2011)

    Fulltext@MSK | Save
  • ACR Appropriateness Criteria® nonsurgical treatment for non-small-cell lung cancer: Good performance status/definitive intent
    Journal Article

    Gewanter, R. M.; Rosenzweig, K. E.; Chang, J. Y.; Decker, R.; Dubey, S.; Kong, F. M.; Lally, B. E.; Langer, C. J.; Lee, H. K.; Movsas, B.
    Current Problems in Cancer (2010)

    Fulltext@MSK | Save